Compile Data Set for Download or QSAR

Found 90 hits with Last Name = 'griffioen' and Initial = 'g'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Alpha-synuclein (Homo sapiens (Human))	BDBM207849 (US9266832, Cpd006) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cn4cccn4)c3)c2c1 Show InChI InChI=1S/C21H19ClN4O/c22-18-5-6-20-19(12-18)17(13-24-20)7-9-23-21(27)16-4-1-3-15(11-16)14-26-10-2-8-25-26/h1-6,8,10-13,24H,7,9,14H2,(H,23,27)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	256	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207852 (US9266832, Cpd009) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccccc3Cc3ccccc3)c2c1 Show InChI InChI=1S/C24H21ClN2O/c25-20-10-11-23-22(15-20)19(16-27-23)12-13-26-24(28)21-9-5-4-8-18(21)14-17-6-2-1-3-7-17/h1-11,15-16,27H,12-14H2,(H,26,28)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	240	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207853 (US9266832, Cpd010) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccccc4)c3)c2c1 Show InChI InChI=1S/C24H21ClN2O/c25-21-9-10-23-22(15-21)20(16-27-23)11-12-26-24(28)19-8-4-7-18(14-19)13-17-5-2-1-3-6-17/h1-10,14-16,27H,11-13H2,(H,26,28)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	78	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207854 (US9266832, Cpd011) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cn4cccn4)cc3)c2c1 Show InChI InChI=1S/C21H19ClN4O/c22-18-6-7-20-19(12-18)17(13-24-20)8-10-23-21(27)16-4-2-15(3-5-16)14-26-11-1-9-25-26/h1-7,9,11-13,24H,8,10,14H2,(H,23,27)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	173	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207855 (US9266832, Cpd012) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cn4ccnc4)cc3)c2c1 Show InChI InChI=1S/C21H19ClN4O/c22-18-5-6-20-19(11-18)17(12-25-20)7-8-24-21(27)16-3-1-15(2-4-16)13-26-10-9-23-14-26/h1-6,9-12,14,25H,7-8,13H2,(H,24,27)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	486	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207858 (US9266832, Cpd015) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccccc4)cc3)c2c1 Show InChI InChI=1S/C24H21ClN2O/c25-21-10-11-23-22(15-21)20(16-27-23)12-13-26-24(28)19-8-6-18(7-9-19)14-17-4-2-1-3-5-17/h1-11,15-16,27H,12-14H2,(H,26,28)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	154	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207861 (US9266832, Cpd018) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(CNCC4CCCCC4)cc3)c2c1 Show InChI InChI=1S/C25H30ClN3O/c26-22-10-11-24-23(14-22)21(17-29-24)12-13-28-25(30)20-8-6-19(7-9-20)16-27-15-18-4-2-1-3-5-18/h6-11,14,17-18,27,29H,1-5,12-13,15-16H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	168	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207862 (US9266832, Cpd019) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(CNCc4ccccc4)cc3)c2c1 Show InChI InChI=1S/C25H24ClN3O/c26-22-10-11-24-23(14-22)21(17-29-24)12-13-28-25(30)20-8-6-19(7-9-20)16-27-15-18-4-2-1-3-5-18/h1-11,14,17,27,29H,12-13,15-16H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	103	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207865 (US9266832, Cpd022) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(CNCc4cccs4)c3)c2c1 Show InChI InChI=1S/C23H22ClN3OS/c24-19-6-7-22-21(12-19)18(14-27-22)8-9-26-23(28)17-4-1-3-16(11-17)13-25-15-20-5-2-10-29-20/h1-7,10-12,14,25,27H,8-9,13,15H2,(H,26,28)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	159	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207866 (US9266832, Cpd023) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(CNCc4ccccc4)c3)c2c1 Show InChI InChI=1S/C25H24ClN3O/c26-22-9-10-24-23(14-22)21(17-29-24)11-12-28-25(30)20-8-4-7-19(13-20)16-27-15-18-5-2-1-3-6-18/h1-10,13-14,17,27,29H,11-12,15-16H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	94	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207867 (US9266832, Cpd024) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(CNC4CCCCC4)c3)c2c1 Show InChI InChI=1S/C24H28ClN3O/c25-20-9-10-23-22(14-20)19(16-28-23)11-12-26-24(29)18-6-4-5-17(13-18)15-27-21-7-2-1-3-8-21/h4-6,9-10,13-14,16,21,27-28H,1-3,7-8,11-12,15H2,(H,26,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	724	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207869 (US9266832, Cpd026) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(CNCc4cccs4)cc3)c2c1 Show InChI InChI=1S/C23H22ClN3OS/c24-19-7-8-22-21(12-19)18(14-27-22)9-10-26-23(28)17-5-3-16(4-6-17)13-25-15-20-2-1-11-29-20/h1-8,11-12,14,25,27H,9-10,13,15H2,(H,26,28)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	83	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207871 (US9266832, Cpd028) Show SMILES Cc1ccccc1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12 Show InChI InChI=1S/C25H23ClN2O/c1-17-4-2-3-5-20(17)14-18-6-8-19(9-7-18)25(29)27-13-12-21-16-28-24-11-10-22(26)15-23(21)24/h2-11,15-16,28H,12-14H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	370	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207872 (US9266832, Cpd029) Show SMILES COc1ccccc1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12 Show InChI InChI=1S/C25H23ClN2O2/c1-30-24-5-3-2-4-19(24)14-17-6-8-18(9-7-17)25(29)27-13-12-20-16-28-23-11-10-21(26)15-22(20)23/h2-11,15-16,28H,12-14H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	84	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207873 (US9266832, Cpd030) Show SMILES COc1ccccc1Cc1cccc(c1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12 Show InChI InChI=1S/C25H23ClN2O2/c1-30-24-8-3-2-6-18(24)13-17-5-4-7-19(14-17)25(29)27-12-11-20-16-28-23-10-9-21(26)15-22(20)23/h2-10,14-16,28H,11-13H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	96	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207874 (US9266832, Cpd031) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccc(cc4)C#N)cc3)c2c1 Show InChI InChI=1S/C25H20ClN3O/c26-22-9-10-24-23(14-22)21(16-29-24)11-12-28-25(30)20-7-5-18(6-8-20)13-17-1-3-19(15-27)4-2-17/h1-10,14,16,29H,11-13H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	16	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207875 (US9266832, Cpd032) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4cccc(c4)C#N)cc3)c2c1 Show InChI InChI=1S/C25H20ClN3O/c26-22-8-9-24-23(14-22)21(16-29-24)10-11-28-25(30)20-6-4-17(5-7-20)12-18-2-1-3-19(13-18)15-27/h1-9,13-14,16,29H,10-12H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	14	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207876 (US9266832, Cpd033) Show SMILES Cc1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C25H23ClN2O/c1-17-2-4-18(5-3-17)14-19-6-8-20(9-7-19)25(29)27-13-12-21-16-28-24-11-10-22(26)15-23(21)24/h2-11,15-16,28H,12-14H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	31	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207877 (US9266832, Cpd034) Show SMILES Cc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C25H23ClN2O/c1-17-5-7-18(8-6-17)13-19-3-2-4-20(14-19)25(29)27-12-11-21-16-28-24-10-9-22(26)15-23(21)24/h2-10,14-16,28H,11-13H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	62	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207878 (US9266832, Cpd035) Show SMILES Cc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C25H23ClN2O/c1-17-4-2-5-18(12-17)13-19-6-3-7-20(14-19)25(29)27-11-10-21-16-28-24-9-8-22(26)15-23(21)24/h2-9,12,14-16,28H,10-11,13H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	60	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207879 (US9266832, Cpd036) Show SMILES Cc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C25H23ClN2O/c1-17-3-2-4-19(13-17)14-18-5-7-20(8-6-18)25(29)27-12-11-21-16-28-24-10-9-22(26)15-23(21)24/h2-10,13,15-16,28H,11-12,14H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	40	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207880 (US9266832, Cpd037) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccc(cc4)C#N)c3)c2c1 Show InChI InChI=1S/C25H20ClN3O/c26-22-8-9-24-23(14-22)21(16-29-24)10-11-28-25(30)20-3-1-2-19(13-20)12-17-4-6-18(15-27)7-5-17/h1-9,13-14,16,29H,10-12H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	32	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207881 (US9266832, Cpd038) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4cccc(c4)C#N)c3)c2c1 Show InChI InChI=1S/C25H20ClN3O/c26-22-7-8-24-23(14-22)21(16-29-24)9-10-28-25(30)20-6-2-4-18(13-20)11-17-3-1-5-19(12-17)15-27/h1-8,12-14,16,29H,9-11H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	31	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207882 (US9266832, Cpd039) Show SMILES FC(F)(F)c1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C25H20ClF3N2O/c26-21-9-10-23-22(14-21)19(15-31-23)11-12-30-24(32)18-5-1-16(2-6-18)13-17-3-7-20(8-4-17)25(27,28)29/h1-10,14-15,31H,11-13H2,(H,30,32)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	22	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207883 (US9266832, Cpd040) Show SMILES FC(F)(F)c1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C25H20ClF3N2O/c26-21-8-9-23-22(14-21)19(15-31-23)10-11-30-24(32)18-3-1-2-17(13-18)12-16-4-6-20(7-5-16)25(27,28)29/h1-9,13-15,31H,10-12H2,(H,30,32)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	103	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207884 (US9266832, Cpd041) Show SMILES FC(F)(F)c1ccccc1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12 Show InChI InChI=1S/C25H20ClF3N2O/c26-20-9-10-23-21(14-20)19(15-31-23)11-12-30-24(32)17-7-5-16(6-8-17)13-18-3-1-2-4-22(18)25(27,28)29/h1-10,14-15,31H,11-13H2,(H,30,32)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	80	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207885 (US9266832, Cpd042) Show SMILES FC(F)(F)c1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C25H20ClF3N2O/c26-21-8-9-23-22(14-21)19(15-31-23)10-11-30-24(32)18-6-4-16(5-7-18)12-17-2-1-3-20(13-17)25(27,28)29/h1-9,13-15,31H,10-12H2,(H,30,32)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	31	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207887 (US9266832, Cpd044) Show SMILES FC(F)(F)c1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C25H20ClF3N2O/c26-21-7-8-23-22(14-21)19(15-31-23)9-10-30-24(32)18-5-1-3-16(12-18)11-17-4-2-6-20(13-17)25(27,28)29/h1-8,12-15,31H,9-11H2,(H,30,32)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207888 (US9266832, Cpd045) Show SMILES Clc1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C24H20Cl2N2O/c25-20-7-3-17(4-8-20)13-16-1-5-18(6-2-16)24(29)27-12-11-19-15-28-23-10-9-21(26)14-22(19)23/h1-10,14-15,28H,11-13H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	22	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207889 (US9266832, Cpd046) Show SMILES Clc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C24H20Cl2N2O/c25-20-3-1-2-17(13-20)12-16-4-6-18(7-5-16)24(29)27-11-10-19-15-28-23-9-8-21(26)14-22(19)23/h1-9,13-15,28H,10-12H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	7	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207890 (US9266832, Cpd047) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccccc4Cl)cc3)c2c1 Show InChI InChI=1S/C24H20Cl2N2O/c25-20-9-10-23-21(14-20)19(15-28-23)11-12-27-24(29)17-7-5-16(6-8-17)13-18-3-1-2-4-22(18)26/h1-10,14-15,28H,11-13H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	65	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207891 (US9266832, Cpd048 | US9266832, Cpd084) Show SMILES Fc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C24H20ClFN2O/c25-20-8-9-23-22(14-20)19(15-28-23)10-11-27-24(29)18-6-4-16(5-7-18)12-17-2-1-3-21(26)13-17/h1-9,13-15,28H,10-12H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	13	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207892 (US9266832, Cpd049) Show SMILES Fc1ccccc1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12 Show InChI InChI=1S/C24H20ClFN2O/c25-20-9-10-23-21(14-20)19(15-28-23)11-12-27-24(29)17-7-5-16(6-8-17)13-18-3-1-2-4-22(18)26/h1-10,14-15,28H,11-13H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	31	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207893 (US9266832, Cpd050) Show SMILES Clc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C24H20Cl2N2O/c25-20-6-4-16(5-7-20)12-17-2-1-3-18(13-17)24(29)27-11-10-19-15-28-23-9-8-21(26)14-22(19)23/h1-9,13-15,28H,10-12H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	50	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207895 (US9266832, Cpd052) Show SMILES Fc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C24H20ClFN2O/c25-20-6-9-23-22(14-20)19(15-28-23)10-11-27-24(29)18-3-1-2-17(13-18)12-16-4-7-21(26)8-5-16/h1-9,13-15,28H,10-12H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	20	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207896 (US9266832, Cpd053) Show SMILES Fc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C24H20ClFN2O/c25-20-7-8-23-22(14-20)19(15-28-23)9-10-27-24(29)18-5-1-3-16(12-18)11-17-4-2-6-21(26)13-17/h1-8,12-15,28H,9-11H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	17	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207897 (US9266832, Cpd054) Show SMILES Fc1ccccc1Cc1cccc(c1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12 Show InChI InChI=1S/C24H20ClFN2O/c25-20-8-9-23-21(14-20)19(15-28-23)10-11-27-24(29)18-6-3-4-16(13-18)12-17-5-1-2-7-22(17)26/h1-9,13-15,28H,10-12H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	42	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207898 (US9266832, Cpd055) Show SMILES Clc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C24H20Cl2N2O/c25-20-6-2-4-17(13-20)11-16-3-1-5-18(12-16)24(29)27-10-9-19-15-28-23-8-7-21(26)14-22(19)23/h1-8,12-15,28H,9-11H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	36	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207899 (US9266832, Cpd056) Show SMILES COc1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C25H23ClN2O2/c1-30-22-9-4-18(5-10-22)14-17-2-6-19(7-3-17)25(29)27-13-12-20-16-28-24-11-8-21(26)15-23(20)24/h2-11,15-16,28H,12-14H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	70	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207900 (US9266832, Cpd057) Show SMILES COc1ccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C25H23ClN2O2/c1-30-22-8-5-17(6-9-22)13-18-3-2-4-19(14-18)25(29)27-12-11-20-16-28-24-10-7-21(26)15-23(20)24/h2-10,14-16,28H,11-13H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	147	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207901 (US9266832, Cpd058) Show SMILES COc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C25H23ClN2O2/c1-30-22-7-3-5-18(14-22)12-17-4-2-6-19(13-17)25(29)27-11-10-20-16-28-24-9-8-21(26)15-23(20)24/h2-9,13-16,28H,10-12H2,1H3,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	125	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207902 (US9266832, Cpd059) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3ccc(Cc4ccccc4C#N)cc3)c2c1 Show InChI InChI=1S/C25H20ClN3O/c26-22-9-10-24-23(14-22)21(16-29-24)11-12-28-25(30)18-7-5-17(6-8-18)13-19-3-1-2-4-20(19)15-27/h1-10,14,16,29H,11-13H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	68	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207903 (US9266832, Cpd060) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Cc4ccccc4C#N)c3)c2c1 Show InChI InChI=1S/C25H20ClN3O/c26-22-8-9-24-23(14-22)21(16-29-24)10-11-28-25(30)19-7-3-4-17(13-19)12-18-5-1-2-6-20(18)15-27/h1-9,13-14,16,29H,10-12H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	116	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207904 (US9266832, Cpd061) Show SMILES Fc1ccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)cc1 Show InChI InChI=1S/C24H20ClFN2O/c25-20-7-10-23-22(14-20)19(15-28-23)11-12-27-24(29)18-5-1-16(2-6-18)13-17-3-8-21(26)9-4-17/h1-10,14-15,28H,11-13H2,(H,27,29)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	86	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207905 (US9266832, Cpd062) Show SMILES Cc1cccc(C)c1Cc1ccc(cc1)C(=O)NCCc1c[nH]c2ccc(Cl)cc12 Show InChI InChI=1S/C26H25ClN2O/c1-17-4-3-5-18(2)23(17)14-19-6-8-20(9-7-19)26(30)28-13-12-21-16-29-25-11-10-22(27)15-24(21)25/h3-11,15-16,29H,12-14H2,1-2H3,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	398	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207907 (US9266832, Cpd064) Show SMILES Clc1ccc2[nH]cc(CCNC(=O)c3cccc(Nc4cccc(c4)C#N)c3)c2c1 Show InChI InChI=1S/C24H19ClN4O/c25-19-7-8-23-22(13-19)18(15-28-23)9-10-27-24(30)17-4-2-6-21(12-17)29-20-5-1-3-16(11-20)14-26/h1-8,11-13,15,28-29H,9-10H2,(H,27,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	122	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207908 (US9266832, Cpd065) Show SMILES Fc1cc(F)cc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C24H19ClF2N2O/c25-19-4-5-23-22(12-19)18(14-29-23)6-7-28-24(30)17-3-1-2-15(9-17)8-16-10-20(26)13-21(27)11-16/h1-5,9-14,29H,6-8H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	174	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207909 (US9266832, Cpd066) Show SMILES COc1cccc(Cc2cccc(c2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1F Show InChI InChI=1S/C25H22ClFN2O2/c1-31-23-7-3-5-17(24(23)27)12-16-4-2-6-18(13-16)25(30)28-11-10-19-15-29-22-9-8-20(26)14-21(19)22/h2-9,13-15,29H,10-12H2,1H3,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	386	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207910 (US9266832, Cpd067) Show SMILES Fc1cc(F)cc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 Show InChI InChI=1S/C24H19ClF2N2O/c25-19-5-6-23-22(12-19)18(14-29-23)7-8-28-24(30)17-3-1-15(2-4-17)9-16-10-20(26)13-21(27)11-16/h1-6,10-14,29H,7-9H2,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	111	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair
Alpha-synuclein (Homo sapiens (Human))	BDBM207911 (US9266832, Cpd068) Show SMILES COc1cccc(Cc2ccc(cc2)C(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1F Show InChI InChI=1S/C25H22ClFN2O2/c1-31-23-4-2-3-18(24(23)27)13-16-5-7-17(8-6-16)25(30)28-12-11-19-15-29-22-10-9-20(26)14-21(19)22/h2-10,14-15,29H,11-13H2,1H3,(H,28,30)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	148	n/a	n/a	n/a	n/a
Katholieke Universiteit Levun; K. U. Leuven R&D reMYND US Patent					Assay Description α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...				US Patent US9266832 (2016) BindingDB Entry DOI: 10.7270/Q2319TP6
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 90 total )  |  Next  |  Last  >>

Jump to: